Copperwynd Financial, LLC Bristol Myers Squibb CO Transaction History

Copperwynd Financial, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $12,326 - $14,596	180 Added 1.01%	17,914 $1.29 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $3,579 - $2.12 Million	-27,535 Reduced 60.83%	17,734 $1.26 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $3.29 Million - $3.62 Million	45,269 New	45,269 $3.49 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Copperwynd Financial, LLC with notifications on news.